Tamsulosin Hydrochloride Capsule
FDA Label NDC 65841-695

1 label section · Submitted to the FDA by Zydus Lifesciences Limited · Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Zydus Lifesciences Limited for the product Tamsulosin Hydrochloride (NDC 65841-695). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding package label.principal display panel, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Package Label.Principal Display Panel

NDC 65841-695-01 in bottle of 100 Capsules

Tamsulosin Hydrochloride Capsules USP, 0.4 mg

Rx only

100 Capsules

Tamsulosin HCl Capsules, 0.4 mg (B05d1829 8334 4145 B49d 6074624bc499 01)

Tamsulosin HCl Capsules, 0.4 mg (B05d1829 8334 4145 B49d 6074624bc499 01)

* Please review the disclaimer below.